AMCo Amdipharm Mercury Pharmaceuticals

About us

Concordia International (formerly AMCo) is part of the Concordia International Corp, a diverse international company focused on legacy pharmaceutical medicines and orphan drugs [please see our Corporate website here]. We have a strong international footprint and supply a diversified portfolio of more than 200 well-established off-patent molecules to patients, partners and healthcare authorities in more than 100 countries [see our Medicines here]. We have an extensive Environmental, Social & Governance programme [see here]

Read more

Latest News

  • 07/11/2016: Third Quarter 2016 Results

    Concordia International Corp. today announced its financial and operational results for the three and nine months ended September 30, 2016.
  • 02/11/2016: New leadership appointments

    Concordia International Corp. today announced that its Board of Directors has appointed Allan Oberman as its new Chief Executive Officer and selected Jordan Kupinsky as Chairman of the Board of Directors

More news

More news

Products

"Concordia International (formerly AMCo) is part of the Concordia International Corp, a diverse international company focused on legacy pharmaceutical products and orphan drugs. We have a number of product ranges, including Concordia products, Amdipharm products, Mercury Pharma products, Abcur products, BnM products and Focus Pharma products. For more information please visit our Products page."

Our Products